0001144204-11-047572.txt : 20110816 0001144204-11-047572.hdr.sgml : 20110816 20110815192907 ACCESSION NUMBER: 0001144204-11-047572 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110630 FILED AS OF DATE: 20110816 DATE AS OF CHANGE: 20110815 EFFECTIVENESS DATE: 20110816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: POWER 3 MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0001063530 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 650565144 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-24921 FILM NUMBER: 111038453 BUSINESS ADDRESS: STREET 1: 3400 RESEARCH FOREST DR STREET 2: SUITE B2-3 CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 281-466-1600 MAIL ADDRESS: STREET 1: 3400 RESEARCH FOREST DR STREET 2: SUITE B2-3 CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: SURGICAL SAFETY PRODUCTS INC DATE OF NAME CHANGE: 19980924 NT 10-Q 1 v232236_nt10q.htm FORM NT-10Q Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 12b-25
 
 
Commission File Number: 000-24921

Notification of Late Filing

(Check one)
o Form 11-K x Form 10-Q o Form N-SAR o Form 10-KSB

For Period Ended: June 30, 2011

o Transition Report on Form 10-K
o Transition Report on Form 20-F
o Transition Report on Form 11-K
o Transition Report on Form 10-Q
o Transition Report on Form N-SAR
 
For the Transition Period Ended: N/A

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I
REGISTRANT INFORMATION

POWER3 MEDICAL PRODUCTS, INC.
Full name of Registrant

_______________________
Former Name if Applicable
 
 
26022 Budde Road
Address of principal executive office (Street and Number)

The Woodlands, TX 77380
City, State and Zip Code

PART II
RULES 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Tule 12b-25(b), the following should be completed.  (Check appropriate box.) [X ] Yes [ ] No

x
(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense.

x
(b) The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or N-SAR, or portion thereof, will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date.

o
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
 
 
 
 
PART III
NARRATIVE

State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The Registrant’s quarterly report on Form 10-Q for the period ended June 30, 2011 will be filed on or before the fifth calendar day following the prescribed due date.  The reason for the delay is that the Registrant did not obtain all information prior to filing date and attorney and accountant could not complete the required legal information and financial statements and management could not complete Management’s Discussion and Analysis of such financial statements by August 15, 2011.

PART IV
OTHER INFORMATION

(1)
Name and telephone number of person to contact in regard to this notification:

Helen Park                      (214)                      202-1566
(Name)                      (Area Code)      (Telephone Number)

(2) 
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or such shorter period that the registrant was required to file such report(s) been filed?  If answer is no, identify report(s). x Yes o No

(3) 
Is it anticipated that any significant change in results of operation for the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? o Yes x No

If so, attach an explanation of anticipated change, both narratively and quantitatively, and if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

POWER3 MEDICAL PRODUCTS, INC.
(Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf
by the undersigned hereunto duly authorized.

Date: August 15, 2011
By: /s/ Helen Park
       Helen Park, CEO

Instruction: The form may be signed by an executive officer of the registrant or by any other duly authorized representative.  The name and title of the person signing the form shall be typed or printed beneath the signature.  If the statement is signed on behalf of the registrant by an authorized representative (other than executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

ATTENTION

Intentional misstatements or omissions of fact constitute Federal criminal violations.  (See 18 U.S.C. 1001)